Cyclic nucleotide phosphodiesterase activity towards cyclic AMP and cyclic GMP was studied in extracts of rat islets of Langerhans. Biphasic Eadie plots [Eadie (1942) 
jM and 103.4 + 13.5 (6)pM for cyclic AMP and 3.6 + 0.3 (12)4um and 61.4 + 7.5 (13)pM for cyclic GMP. With cyclic AMP as substrate, phosphodiesterase activity was increased by calmodulin and Ca2+ and decreased by trifluoperazine, a specific inhibitor of calmodulin. With cyclic GMP as substrate, phosphodiesterase activity was decreased by omission of Ca2+ or addition of trifluoperazine. Addition of exogenous calmodulin had no effect on activity. The data suggest that Ca2+ may influence the islet content of cyclic AMP and cyclic GMP via effects on calmodulin-dependent cyclic nucleotide phosphodiesterase(s).
A rise in the intracellular concentration of free Ca2+ is believed to trigger insulin release by the pancreatic 3-cell. The mediator of the regulatory effects of Ca2+ on insulin secretion may be the Ca2+-dependent regulator calmodulin. Thus glucose-stimulated insulin release is inhibited by trifluoperazine, a specific inhibitor of calmodulin function. This inhibition is not due to impairment of islet viability or glucose utilization (Sugden et al., 1979; Gagliardino et al., 1980) .
The role of calmodulin in insulin secretion is not known. Calmodulin has been implicated in the regulation of brain adenylate cyclase (Brostrom et al., 1975) and phosphodiesterase (Cheung, 1970; Kakiuchi et al., 1970) and one possible site of action for calmodulin in insulin secretion might therefore be regulation of islet cyclic nucleotide concentrations. It has recently been reported that islet adenylate cyclase is activated by calmodulin (Valverde et al., 1979) . The present experiments demonstrate that islet cyclic AMP phosphodiesterase is also stimulated by calmodulin. This stimulation is not observed in the absence of Ca +. Such activation may terminate the effects of secretagogues that act by stimulation of adenylate cyclase (for review, see Sharp, 1979) and may explain the transient nature of the increase in cyclic AMP observed when islets are exposed to glucose (Zawalich et al., 1975) . We also report the existence of cyclic GMP phosphodiesterase activity in rat pancreatic islets. Kinetic constants for these activities were determined. Cyclic GMP phosphodiesterase activity was inhibited by trifluoperazine (a specific inhibitor of calmodulin; Levin & Weiss, 1977) or omission of Ca2+, but was not activated by addition of exogenous calmodulin.
phosphodiesterase has been described in detail previously (Sugden et al., 1979) .
Preparation ofislet extracts
Islets were obtained by collagenase digestion (Coll-Garcia & Gill, 1969) from the pancreases of 300g male albino Wistar rats fed ad libitum. Islets (300) were disrupted in 300,u1 of 10mM-Tris/HC1, pH 8, by sonication (3 x 5 s on Soniprobe Dawe Instruments, point 1) and the extract was kept at 40C until use.
Assay ofcyclic nucleotide phosphodiesterase
The method for the measurement of cyclic nucleotide phosphodiesterase activity with cyclic AMP as substrate has been described in detail (Sugden et al., 1979 and quantified by liquid-scintillation spectrometry as previously described (Sugden et al., 1979) . The procedure for measuring cyclic GMP phosphodiesterase activity was as described above but using cyclic [3HIGMP as substrate.
Results

Kinetic analysis of rat islet cyclic nucleotide phosphodiesterase activities
Previous studies have demonstrated that mouse (Ashcroft et al., 1972) and guinea-pig (Sams & Montague, 1972) and 20 to 500,UM for low-and high-Km activities respectively (Sams & Montague, 1972; Ashcroft et al., 1972; Capito & Hedeskov, 1974; Schubart et al., 1974) . Mean (+S.E.M.) values of Vmax for the two phosphodiesterase activities were 29.3 + 1.9 (n = 8) pmol/h per islet and 37.9 + 3.2 (6) pmol/h per islet.
Analogous plots were drawn for rat islet phosphodiesterase activity with cyclic GMP as substrate (Fig. 1) Effects of calmodulin on rat islet cyclic GMP phosphodiesterase activities In contrast with rat islet cyclic AMP phosphodiesterase activity, rat islet cyclic GMP phosphodiesterase activity was inhibited by omission of Ca2+ (and addition of EGTA). Trifluoperazine addition also decreased islet cyclic GMP phosphodiesterase activity (Fig. 3) . The decrease was similar in magnitude to that produced by omission of Ca2+ (Fig. 3) . In the presence of trifluoperazine, omission of Ca2+ did not elicit a further decrease in islet GMP phosphodiesterase activity (Fig. 3 ). These observations strongly suggest t4at trifluoperazine addition and Ca2+ omission inhibit cyclic GMP phosphodiesterase by a common mechanism, i.e. inhibition of calmodulin function. However, in the presence of Ca2 , the addition of exogenous calmodulin did not increase the rate of cyclic GMP hydrolysis (Fig. 4) .
Discussion
The important role ascribed to Ca2+ in the regulation of insulin release and the hypothesis that effects of Ca2+ may be mediated by calniodulin Table 1 . Effects ofCa2+, trifluoperazine and calmodulin on islet cyclic AMP phosphodiesterase activity
The phosphodiesterase activity of rat islet extracts was measured as described in the Experimental section with 100pM-cyclic AMP as substrate in the absence of Ca2+ and presence of 1 mM-EGTA (-Ca2+) or in the presence of 50,uM-Ca2+ (+Ca2 ). Trifluoperazine (60pM) or calmodulin (2,ug/ml) were present where indicated. Results are means + S.E.M. for five separate preparations and the probability of no real difference between the rates under the condition indicated was assessed by the paired Student's t test. Abbreviation used: NS, not significant. . Effect of exogenous calmodulin on islet cyclic GMPphosphodiesterase Islet cyclic GMP phosphodiesterase activity was determined at various concentrations of cyclic GMP in the absence (0) or presence (A) of calmodulin (2#g/ml). (Sugden et al., 1979; Gagliardino et al., 1980; Ashcroft, 1980) have prompted a search for Ca2+/ calmodulin-dependent activities in pancreatic islets. Evidence has been presented for Ca2+/calmodulindependent protein phosphorylation (Gagliardino et al., 1980) and adenylate cyclase activity (Valverde et al., 1979) . Since calmodulin was originally discovered as an activator of phosphodiesterase (Cheung, 1970) , the present study was concerned with assessing the possible dependence of islet cyclic nucleotide phosphodiesterase on Ca2+ and calmo-1981 dulin. The studies are. complicated by the obvious heterogeneity of such activity in islets. Kinetic evidence from this and previous studies (Ashcroft et al., 1972) indicates at least two forms with differing affinities for cyclic AMP. Moreover there may be distinct species responsible for the hydrolysis of cyclic AMP and cyclic GMP. The present studies also suggest that sensitivity to Ca2+ (via calmodulin) may be a property of only a fraction of the total activity. Nevertheless the results described here show that hydrolysis of both cyclic AMP and cyclic GMP catalysed by islet phosphodiesterase activities is capable of being modulated by Ca2+/calmodulin. Thus with cyclic AMP as substrate, the addition of calmodulin in the presence of Ca2+ elicits an increase in phosphodiesterase activity that is blocked by trifluoperazine. However, the stimulation is only some 10-20%, with an amount of calmodulin that gives some 6-fold stimulation of calmodulin-free brain phosphodiesterase (Sugden et al., 1979) . This suggests that either the islet phosphodiesterase in the extracts is partially activated by endogenous calmodulin or the major portion of the activity is not sensitive to Ca2+/calmodulin. That the latter is the correct explanation is suggested by the lack of effect of Ca2+ omission on the cyclic AMP phosphodiesterase activity in the absence of added calmodulin; and also by the fact that substantial activity remains in the presence of trifluoperazine.
With cyclic GMP as substrate, however, somewhat different findings were observed. Hydrolysis of cyclic GMP was not augmented by exogenous calmodulin. This might imply that the cyclic GMP phosphodiesterase activities are entirely Ca2+/ calmodulin-independent species. This does not seem to be the case, however, since cyclic GMP hydrolysis was clearly inhibited, although not abolished, in the absence of Ca2+. That this partial dependence on Ca2+ may be mediated by calmodulin present in the extract is suggested by the finding that trifluoperazine inhibited cyclic GMP hydrolysis to the same extent as did the omission of Ca2+.
These data thus support the view that Ca2 , via calmodulin, may play a role in the regulation of the islet content of both cyclic AMP and cyclic GMP. A modulatory role for cyclic AMP in insulin release is well documented (for review see Sharp, 1979) . When the present findings are considered together with the reported activation of adenylate cyclase by Ca2+/ calmodulin (Valverde et al., 1979) one may speculate that such a dual action of Ca2+ could underlie the kinetics of changes in islet cyclic AMP content in response to glucose, i.e. an initial rise followed by a decline (Zawalich et al., 1975) .
There is evidence that cyclic GMP may affect insulin biosynthesis (Lin et al., 1979; Howell & Montague, 1974) . However, there is no evidence that changes in islet cyclic GMP concentration modulate glucose-induced insulin release; thus in the presence of stimulatory concentration of glucose (Howell & Montague, 1974; Gagerman & Hellman, 1977) or glucose plus arginine (Charles et al., 1976) islet content of cyclic GMP was unchanged. An increase in cyclic GMP content of guinea-pig islets stimulated by acetylcholine has been reported (Howell & Montague, 1974) but, in mouse islets, although acetylcholine elicited insulin release and membrane electrical activity no change in cyclic GMP could be detected (Gagerman et al., 1978) .
A role for Ca2+ in activation of islet guanylate cyclase is suggested by the observation that removal of extracellular Ca2+ reduced the cyclic GMP content of islets from ob/ob mice (Gagerman & Hellman, 1977) and by direct measurement of islet guanylate cyclase activity (Howell & Montague, 1974) . The present study indicates that Ca2+ could also regulate the rate of degradation of cyclic GMP.
